Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 3/1998

01-03-1998 | Pharmacoepidemiology

ACE Inhibitor-Induced Angioedema

Incidence, Prevention and Management

Authors: Dr Wim Vleeming, Jan G. C. van Amsterdam, Bruno H. Ch. Stricker, Dick J. de Wildt

Published in: Drug Safety | Issue 3/1998

Login to get access
Metadata
Title
ACE Inhibitor-Induced Angioedema
Incidence, Prevention and Management
Authors
Dr Wim Vleeming
Jan G. C. van Amsterdam
Bruno H. Ch. Stricker
Dick J. de Wildt
Publication date
01-03-1998
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 3/1998
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199818030-00003

Other articles of this Issue 3/1998

Drug Safety 3/1998 Go to the issue

Drug Safety Concept

Diabetes Mellitus in Pregnancy

Pharmacoepidemiology

Behavioural Toxicity of Medicinal Drugs

Leading Article

The Application of Adverse Drug Reaction Data to Drug Choice Decisions Made by Pharmacy and Therapeutics Committees

Risk-Benefit Assessment

A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia